Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 AUD | +13.21% | +16.88% | +190.32% |
Apr. 01 | ADRs End Higher; Connect Biopharma Climbs 26% | DJ |
Mar. 28 | ADRs End Lower; NuCana Slides 15% | DJ |
Sales 2024 * | 11.52M 7.43M | Sales 2025 * | 24.97M 16.11M | Capitalization | 907M 586M |
---|---|---|---|---|---|
Net income 2024 * | -103M -66.48M | Net income 2025 * | -124M -80.03M | EV / Sales 2024 * | 83.6 x |
Net Debt 2024 * | 55.05M 35.53M | Net Debt 2025 * | 93.28M 60.2M | EV / Sales 2025 * | 40.1 x |
P/E ratio 2024 * |
-7.5
x | P/E ratio 2025 * |
-7.38
x | Employees | 83 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.79% |
Latest transcript on Mesoblast Limited
1 day | +13.21% | ||
1 week | +16.88% | ||
Current month | +62.16% | ||
1 month | +172.73% | ||
3 months | +233.33% | ||
6 months | +143.24% | ||
Current year | +190.32% |
Managers | Title | Age | Since |
---|---|---|---|
Silviu Itescu
FOU | Founder | 67 | 04-06-07 |
Andrew Chaponnel
DFI | Director of Finance/CFO | - | 12-05-31 |
Chief Operating Officer | 60 | 20-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 73 | 13-04-14 |
Joseph Swedish
CHM | Chairman | 72 | 18-06-17 |
William Burns
BRD | Director/Board Member | 76 | 14-03-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.9 | +13.21% | 12 954 191 |
24-04-22 | 0.795 | +3.92% | 4,496,481 |
24-04-19 | 0.765 | -1.29% | 6,472,845 |
24-04-18 | 0.775 | +3.33% | 7,394,392 |
24-04-17 | 0.75 | -2.60% | 8,171,310 |
Delayed Quote Australian S.E., April 23, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+190.32% | 584M | |
-0.02% | 42.11B | |
+45.38% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- MSB Stock